Literature DB >> 9659769

The cost-effectiveness of home assessment and modification to reduce falls in the elderly.

R D Smith1, D Widiatmoko.   

Abstract

Injury sustained through falling is a significant risk for the elderly and a significant burden on the health service. Although many risk factors have been detected and interventions proposed, there remains limited evidence concerning the cost-effectiveness of fall prevention. This study addressed the cost-effectiveness of a home assessment and modification program hypothesised to reduce risk of falling for the independent elderly. Due to a lack of direct clinical trial evidence concerning such an intervention, a decision analytic model was developed to simulate the potential costs and outcomes of the intervention. The model was developed using available published literature concerning injury in the elderly, focusing on Australian data where possible. Cost-effectiveness was estimated as the cost per fall prevented and cost per injury prevented. Over a one-year period, the incremental cost of introducing the intervention was $172 per person, resulting in an incremental cost per fall prevented of $1,721 and cost per injury prevented of $17,208. Over a 10-year period, the intervention resulted in a cost saving of $92 per person (i.e. dominance, with cost savings in addition to reduced falls and injuries). This analysis indicates that there is potential for considerable benefit to be gained from this intervention, in terms of less morbidity, fewer hospitalisations and, possibly, improved quality of life. However, these results are based on a model constructed from various data sources and assumptions so, although results are indicative, further research is required to provide firm data before definitive policy conclusions and recommendations may be made.

Entities:  

Mesh:

Year:  1998        PMID: 9659769     DOI: 10.1111/j.1467-842x.1998.tb01410.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  8 in total

Review 1.  [Controlled trials on the efficacy of occupational therapy with elderly. Part II: Evidence for prioritized diseases and disabilities].

Authors:  S Voigt-Radloff; T Schochat; H W Heiss
Journal:  Z Gerontol Geriatr       Date:  2004-12       Impact factor: 1.281

2.  The Falls/Fractures Economic Model in Ontario Residents Aged 65 Years and Over (FEMOR).

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2008-10-01

3.  Systematic review of unintentional injury prevention economic evaluations 2010-2019 and comparison to 1998-2009.

Authors:  Mallika Mahalingam; Cora Peterson; Gwen Bergen
Journal:  Accid Anal Prev       Date:  2020-09-09

4.  Cost Effectiveness of Falls and Injury Prevention Strategies for Older Adults Living in Residential Aged Care Facilities.

Authors:  Jody L Church; Marion R Haas; Stephen Goodall
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

5.  Cost-effectiveness of injury prevention - a systematic review of municipality based interventions.

Authors:  Harald Gyllensvärd
Journal:  Cost Eff Resour Alloc       Date:  2010-09-10

6.  Feasibility and cost-effectiveness of a multidisciplinary home-telehealth intervention programme to reduce falls among elderly discharged from hospital: study protocol for a randomized controlled trial.

Authors:  Alessandro Giordano; Gian Pietro Bonometti; Fabio Vanoglio; Mara Paneroni; Palmira Bernocchi; Laura Comini; Amerigo Giordano
Journal:  BMC Geriatr       Date:  2016-12-07       Impact factor: 3.921

7.  Economic evaluation of community-based falls prevention interventions for older populations: a systematic methodological overview of systematic reviews.

Authors:  Joseph Kwon; Hazel Squires; Matthew Franklin; Yujin Lee; Tracey Young
Journal:  BMC Health Serv Res       Date:  2022-03-26       Impact factor: 2.655

Review 8.  A systematic review of the unit costs of allied health and community services used by older people in Australia.

Authors:  Inez Farag; Cathie Sherrington; Manuela Ferreira; Kirsten Howard
Journal:  BMC Health Serv Res       Date:  2013-02-20       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.